Research Guide · Weekly
Weekly Briefings
A short, evidence-based read on the week's most consequential U.S. healthcare developments.
Each Monday we select the developments that matter most for access, affordability, quality, accountability, and reform. Proposals are kept separate from enacted policy, dates are stated, and primary sources are linked wherever they exist. Items are connected to the research behind this site.
Weekly Briefings complement Current Events: Current Events holds the individually scored entries, while each briefing gives a quick weekly read across the whole landscape. Subscribe via feed.
Latest
Briefings
Briefing for the week of September 30 – October 7, 2026
Published October 8, 2026 · 8 developments
CMS finalized a much narrower drug-pricing model than first proposed, insurers pulled back Medicare Advantage benefits for 2027, Medicaid work-requirement timelines drew pushback from governors, and new federal rules reshaped insurer price disclosure.
Storylines
Follow a Story Over Time
Medicare Advantage in 2027
Plan benefits, premiums, enrollment, and federal audit enforcement as insurers reset for the 2027 plan year.
Medicaid Cuts and Eligibility
Work requirements, financing limits, and eligibility changes flowing from the 2025 reconciliation law.
Drug Pricing and the GLOBE Model
Federal efforts to tie Medicare drug payment to international benchmarks, and how far they actually reach.
Price Transparency
Rules requiring insurers and providers to disclose prices, and whether disclosure changes what patients pay.
Coverage and Affordability
Marketplace premiums, expired subsidies, and ad hoc payments as the cost of coverage rises.
Market Concentration
Pharmacy benefit managers, drug-pricing programs, and the consolidation that shapes who controls prices.